je.st
news
Tag: drug
Emulate's Lung-Chip Demonstrates New Capabilities To Predict Human Lung Inflammation And Drug Responses In Asthma And COPD
2016-01-06 06:32:00| drugdiscoveryonline Home Page
Emulate Inc. announced recently that it has developed a new living human Lung-Chip system that accurately recreates the unique structure and function of the human lung small airways within microengineered chips - as reported today in the journal Nature Methods
Tags: human
drug
responses
capabilities
Emulate Announces Expanded Collaboration With Merck To Use Organ-Chips In Drug Discovery And Development Process For Inflammatory Diseases
2016-01-06 06:17:13| drugdiscoveryonline Home Page
Emulate Inc. recently announced an expanded research collaboration with Merck, known as MSD outside the United States and Canada, to deploy Emulate’s Organ-Chips across certain Merck discovery programs to improve models of human inflammatory diseases and better predict the potential human response of therapeutic candidates
Tags: development
process
drug
expanded
Oncodesign Biotechnology And Bristol-Myers Squibb Enter Into Strategic Drug Discovery Collaboration
2016-01-06 06:00:34| drugdiscoveryonline Home Page
ONCODESIGN (Alternext – ALONC), a biotechnology company serving the pharmaceutical industry in the discovery of new therapeutic molecules to fight cancer and other serious illnesses with no known effective treatment, recently announced that it has entered into a strategic collaboration agreement with Bristol-Myers Squibb Company to discover, develop and commercialize novel macrocyclic compounds
Tags: enter
drug
collaboration
strategic
Teva, Active Biotech halt higher doses of oral MS drug in trials
2016-01-04 16:59:51| Biotech - Topix.net
Teva Pharmaceutical Industries and Active Biotech will discontinue higher doses of their oral drug in development for multiple sclerosis in two trials, citing the occurrence of non-fatal cardiovascular events in eight patients. Both trials of laquinimod will continue with the lower dose of 0.6 mg daily where there were no issues.
Coal-dependent states lose jobs and gain drug addiction. What to do?
2016-01-04 15:00:00| Climate Ark Climate Change & Global Warming Newsfeed
Forbes: It could be the cruelest quandary of all: to bless a region with a once-rich natural resource only to have it lose favor decades later to cleaner fuels. The resulting devastation is now occurring in Appalachia, not just economically but also emotionally, as drug addition among local inhabitants is at dangerous levels. The scourge is especially profound in Central Appalachia because of falling coal demand, thinning coal seams and rising air quality standards all compounded by the abuse of prescription...
Sites : [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] next »